UCB calls all artists in the mitochondrial disease community
This year UCB is collaborating with the global Mitochondrial disease community to collect works of art (painting, poetry, photography, sculpture, […]
This year UCB is collaborating with the global Mitochondrial disease community to collect works of art (painting, poetry, photography, sculpture, […]
Five years ago, a research project began that is now influencing anesthetic practice worldwide. It all started when Dr. Yaremy
First Patient Dosed in Phase 3 KHENERFIN Study of Sonlicromanol for m.3243A>G Primary Mitochondrial Disease Khondrion has announced a major
European Commission approves KYGEVVI® for TK2d IMP warmly welcomes the decision by the European Commission to approve KYGEVVI® (doxecitine and doxribtimine) as
Announcing IMP’s New Scientific and Medical Advisory Committee IMP is delighted to introduce our new Scientific and Medical Advisory Committee, a
New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide In November 2025, leading international experts gathered in Pisa,
MitMED – Building a European Centre of Excellence in Mitochondrial Medicine Mitochondria are central regulators of cellular life, integrating metabolism,
Growing Recognition of the Patient Voice in Research A meaningful shift is taking place in the rare disease research landscape:
Inside the Mito Town Hall: Insights That Matter The Mito Town Hall meetings have become an important annual touchpoint for
The Mitochondrial Disease Conference 2026, hosted by Mitocon on 23–24 January in Pisa, brought together clinicians, researchers, patients, and industry partners for